Strategic and Business Planning ANZUP’s 2010-2012 Strategic plan (www.anzup.org.au) was developed to provide a framework for identifying our priorities and a pathway to achieve our goals. It involved identifying Directors with legal, corporate, accounting, and consumer expertises to broaden our skill set and strengthen the organisation’s foundation and governance. We continued to build on our research capacity, extending collaborations and mentoring young investigators. The Board has reviewed its Strategic Plan for the next three years (2013-2015) and it will be presented to members at the AGM on July 16, 2012. You can find it on the next two pages of this publication. The Board is also reviewing the Constitution to clarify processes relating to terms of appointment and succession planning.
Changes in state of affairs: In accordance with section 8.13(a) of the ANZUP Constitution, Ian Davis resigned as an elected Director at the 2011 Annual General Meeting and was re-elected as Director and Chair. A part-time project officer (Yi Feng) was employed as of Monday 16 May 2011. The Executive Officer (Margaret McJannett) moved from 0.6 to 0.8 EFT in January 2012. On 28 April, 2011 ANZUP held an Extraordinary General Meeting (EGM). The purpose of the EGM was to remove Moore Stephens, as auditor of the company, and appoint PKF Chartered Accountants and Business Advisors as ANZUP’s auditor. The resolution was passed unanimously by all those in attendance. ANZUP held it’s second Annual General Meeting on Friday 5 August 2011.
The Strategic Plan for 2013-2015 will be presented at the AGM on July 16, 2012.
10
Matters affecting ANZUP operations and state of affairs in future financial years Approval of recurrent funding from Cancer Australia under its Support for Clinical Trials scheme was confirmed, covering the period 1 January 2012 to 30 June 2013. ANZUP formally partnered with the Clinical Oncological Society of Australia to conduct a joint Annual Scientific Meeting from 14-17 November 2011. Additional funding sources will need to be identified in order to support the proposed expansion of activities of ANZUP.
Likely developments in operations and expected results ANZUP plans to continue its employment of an Executive Officer with a view to moving this position to full time when resources permit, and to continue to employ a Project Officer. Further expansion in staff may be necessary depending on the scope of activities. This will only be possible with additional funding. ANZUP plans to continue to develop clinical trials and aims to activate 1-2 new protocols per year.
Funding from Cancer Australia confirmed until 30 June 2013.
